By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Veracyte, Inc. 

6000 Shoreline Court

South San Francisco  California  94080  U.S.A.
Phone: 650-243-6300 Fax: 650-243-6301


SEARCH JOBS


Industry
Diagnostics






Company News
Veracyte (VCYT) Announces Publication Of Study Supporting The Development Of Envisia Genomic Classifier For IPF In Annals Of The American Thoracic Society 6/27/2017 8:12:05 AM
Veracyte (VCYT) Announces Clinical Validation Data Demonstrating Envisia Genomic Classifier's Performance In Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented At American Thoracic Society 2017 5/24/2017 6:57:55 AM
Veracyte (VCYT) Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis 5/19/2017 6:44:27 AM
Veracyte (VCYT) Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis 5/18/2017 7:52:45 AM
Data Demonstrating Cost-Effectiveness Of Veracyte (VCYT)'s Percepta Bronchial Genomic Classifier Published In "Journal Of Thoracic Oncology" 5/11/2017 8:10:16 AM
Data Presented At AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte (VCYT)'s Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis 5/8/2017 7:38:35 AM
Veracyte (VCYT) Announces Pivotal Clinical Validation Data For Next-Generation Afirma Test To Help More Patients Avoid Unnecessary Surgery In Thyroid Cancer Diagnosis 5/5/2017 6:48:17 AM
Veracyte (VCYT) Announces First Quarter 2017 Financial Results 5/4/2017 9:31:03 AM
Multiple Studies Presented At ENDO 2017 Support Use Of Veracyte (VCYT)'s Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis 4/4/2017 8:52:47 AM
Veracyte (VCYT) Announces Fourth Quarter And Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 3/2/2017 8:56:01 AM
12345678910...
//-->